BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30921254)

  • 21. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature.
    Molina-Infante J; Ferrando-Lamana L; Mateos-Rodríguez JM; Pérez-Gallardo B; Prieto-Bermejo AB
    World J Gastroenterol; 2008 Mar; 14(9):1463-6. PubMed ID: 18322968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance Endoscopy in Pediatric Esophageal Atresia: Toward an Evidence-Based Algorithm.
    Yasuda JL; Kamran A; Servin Rojas M; Hayes C; Staffa SJ; Ngo PD; Chang D; Hamilton TE; Demehri F; Mohammed S; Zendejas B; Manfredi MA
    J Am Coll Surg; 2024 May; 238(5):831-843. PubMed ID: 38078620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Akahoshi T; Kawanaka H; Tomikawa M; Saeki H; Uchiyama H; Ikeda T; Shirabe K; Hashizume M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):483-9. PubMed ID: 24693675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
    Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S
    J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilic esophagitis in children with esophageal atresia.
    Dhaliwal J; Tobias V; Sugo E; Varjavandi V; Lemberg D; Day A; Bohane T; Ledder O; Jiwane A; Adams S; Henry G; Dilley A; Shi E; Krishnan U
    Dis Esophagus; 2014; 27(4):340-7. PubMed ID: 23947919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of erosive reflux esophagitis after Nissen fundoplication.
    El-Serag HB; Sonnenberg A
    Am J Gastroenterol; 1999 Jul; 94(7):1771-6. PubMed ID: 10406233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors, antibiotics, and atopy increase the risk of eosinophilic esophagitis in children with esophageal atresia.
    Tang TC; Leach ST; Krishnan U
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1317-1328. PubMed ID: 38409891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term (15-year) objective evaluation of 150 patients after laparoscopic Nissen fundoplication.
    Csendes A; Orellana O; Cuneo N; Martínez G; Figueroa M
    Surgery; 2019 Nov; 166(5):886-894. PubMed ID: 31227185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine.
    Simeone D; Caria MC; Miele E; Staiano A
    J Pediatr Gastroenterol Nutr; 1997 Jul; 25(1):51-5. PubMed ID: 9226527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy.
    Shaheen NJ; Denison H; Björck K; Silberg DG
    Am J Gastroenterol; 2013 Apr; 108(4):529-34. PubMed ID: 23318482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999.
    DeBrosse CW; Collins MH; Buckmeier Butz BK; Allen CL; King EC; Assa'ad AH; Abonia JP; Putnam PE; Rothenberg ME; Franciosi JP
    J Allergy Clin Immunol; 2010 Jul; 126(1):112-9. PubMed ID: 20620567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study.
    Okanobu H; Kohno T; Boda K; Ochi H; Furukawa Y
    Digestion; 2023; 104(4):283-290. PubMed ID: 36716726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme.
    Donoso F; Beckman A; Malinovschi A; Engstrand Lilja H
    PLoS One; 2022; 17(4):e0266995. PubMed ID: 35427378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.